Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Sunday
Mar 14th
Home arrow Farmavita.Net Journal
Farmavita.Net Journal
Print E-mail
Market Report

datamonitor_logo.gifDiabetes

Type 2 diabetes is an emerging epidemic driven by the escalating prevalence of obesity and by an ageing population. Diagnosis rates will continue to increase as improved awareness raises the public profile of the disease. Despite several established classes of oral anti-diabetic agents an unmet need for a safe, efficacious agent which can halt or reverse long-term disease progression remains.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Acute Coronary Syndromes Fresh look at ACS in Europe, what is the real picture

The face of ACS is changing. The ageing population and pressure of growing risk factors have made a significant impact on the management strategies in ACS. This report unveils the true picture through in-depth analysis of data on over 21,000 ACS patient records in the 5 major European pharmaceutical markets (5EU; France, Germany, Italy, Spain and the UK).

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gifUrinary Incontinence - Lifecycle management strategies retain mid-term market growth

The UI market is set to continue to grow over the next 6 years, reaching over $2.5 billion in 2012, a 68% increase from 2006. Lifecycle management strategies, novel formulations and follow-on products will drive the majority of this growth, with key brands expected to be Pfizer's Detrol LA (tolterodine) and Toviaz (fesoterodine), GSK's Vesicare (solifenacin), and Novartis' Enablex (darifenacin).

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gifAutoimmune Overview - Market continues to prosper

The autoimmune disease market will be rapidly growing due to a high number of competitive brands currently on the market and a full pipeline. Company strategies include expanding the treatment algorithm by pursuing approval for 'early' disease stages, launching easy-to-use devices to make up for downsides of injectable drugs, and developing fully human monoclonal antibodies as follow-on products.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gifBenchmarking key countries Brazil, Russia, India, China and Turkey

With dwindling growth rates observed in the major developed markets many pharmaceutical companies are turning towards emerging market countries in order to sustain their revenue growth. While some countries, with double digit growth rates present tremendous opportunities, there are also many obstacles that need to be overcome.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gifReaching Doctors and Patients Through New Digital Media

Existing sales and marketing models are considered unsustainable. Pharma has been slow to adapt and take advantage of the marketing opportunities offered by the internet. Meanwhile customers are increasingly using the web to source information. Pharma needs to evolve and engage with their customers online, or risk being left behind.

Read more...
 
Print E-mail
Market Report

business-insights-logo.gif

The CNS Market Outlook to 2011

Psychiatric and neurological disorders constitute as much as 35% of the disease burden in the seven major pharmaceutical markets, representing continuing opportunities for pharma companies in the CNS market.

Read more...
 
Print E-mail
Market Report

business-insights-logo.gifFuture Growth Opportunities in Generics: Impact of consolidation on market and competitive dynamics

The number of commercially lucrative drugs coming off patent has catalyzed the growth of the generics industry, creating significant profit opportunities for generics manufacturers. However, this market faces a considerable number of threats, with bulk manufacturers from developing countries becoming internationally competitive and the aggressive actions of branded pharmaceutical marketers in protecting their patent and market position resulting in ramifications for the sector as a whole.

Read more...
 
Print E-mail
Product Report

business-insights-logo.gifInnovation in Drug Delivery: The future of nanotechnology and non-invasive protein delivery

Innovation in Drug Delivery provides an in-depth examination of product launches and pipeline drugs with novel drug delivery mechanisms set to revolutionize the market, such as products using ALZA Corporation’s E-TRANS and Altea’s PassPort patch transdermal technologies.

Read more...
 
Print E-mail
Product Report

business-insights-logo.gif

Next-Generation Nutraceuticals: Food and pharma convergence

Next-Generation Nutraceuticals is a new report published by Business Insights that provides analysis of how the food and pharmaceutical industries are becoming more aligned in their approach to consumer health.

Read more...
 
Print E-mail
Company Report

business-insights-logo.gifBiopartnering Strategies: Maximizing returns from biotechnology deal-making

Biopartnering Strategies is a unique report from the Drug Discovery series that provides an essential guide to the biopartnering process, for both in-licensing and out-licensing companies.

Read more...
 
Print E-mail
Product Report

business-insights-logo.gif

Innovations in CNS: Novel therapeutics and future RandD strategies

The CNS drug market presents significant profit opportunities, but also carries high risks for companies aiming to achieve blockbuster status.

Read more...
 
Print E-mail
Market Report

business-insights-logo.gif

The Cardiovascular Market Outlook to 2011

The Cardiovascular Market Outlook to 2011 is a new report from Business Insights providing analysis of the current and future market for cardiovascular drugs across all major indications. Forecasts are given based on new product launches, upcoming patent expiry dates, and ongoing clinical trials to enable you to predict changes in the dynamics of the global cardiovascular market.

Read more...
 
Print E-mail
Market Report

business-insights-logo.gif

Innovations in Cancer: Novel therapeutics, new diagnostics and future RandD strategies

The cancer market is highly dynamic, creating a new age of discovery and innovation driven by molecular biology, oncogenomics and new methods in cell biology.

Read more...
 
Print E-mail
Product Report

business-insights-logo.gif

Next Generation Protein Engineering & Drug Design: Strategies to boost efficacy

The success of protein and peptide therapeutics is revolutionizing the biotech and pharmaceutical market, spurring the creation of next-generation products with reduced immunogenicity, improved safety and greater effectiveness.

Read more...
 
Print E-mail
Market Report

business-insights-logo.gifThe Dermatology Market Outlook to 2011

The Dermatology Market Outlook to 2011 provides detailed analysis on 5 indications within the dermatology market, identifying high growth brands, future market leaders and key drug classes.

Read more...
 
Print E-mail
Market Report

business-insights-logo.gif

eHealth Solutions for Pharma: Strategies for salesforces, marketing and patient compliance

The online channel offers a key opportunity for pharma companies to restructure their sales and marketing model, improving their relationships with physicians and increasing compliance among patients.

Read more...
 
Print E-mail
Company Report

business-insights-logo.gifIndication Expansion: Opportunities for successful lifecycle management

Due to shrinking pipelines and rising financial pressures on pharmaceutical companies, indication expansion is an increasingly attractive strategy to expand patient potential and extend market exclusivity.

Read more...
 
Print E-mail
Product Report

business-insights-logo.gif

Winning Product Launch Strategies: Maximizing sales from new pharmaceutical products

With pharmaceutical R&D continuing to suffer from declining productivity levels and stagnant returns on investment, effective, flexible and commercially successful new product launches have become more important than ever.

Read more...
 
<< Start < Prev 11 12 13 14 15 16 17 18 Next > End >>

Results 267 - 285 of 329
Advertisement
  • Networking Tips & Tricks

    Monitoring Downloads Section

    You can easily monitor all new articles and reports published  at Downloads Section of Farmavita.Net. Click on the RSS button and bookmark this RSS feed.  RSS button is located beside title “Farmavita.Net - Pharmaceutical Licensing Network :: File Repository“.

     
  • Latest Published
 

Featured Video

More videos ...

3D Content Cloud

Featured Partners

farmavita_research-store.gif
top-20-cancer-therapy-brand.jpg
generics-growth-strategies2.gif
sfe_eu10_150x150_v2.gif 
mddexeceu10_150x150_v1.gif
discovery2010_150x150.gif
150x150_salesonco-master.gif
pharma_omaeu10_150x150_v2.gif
risksharingnextlevel.gif 
arriello-150x150.gif 
150x150_ceepr3_master.gif 
pharmabrand2010_150x150.gif
 

Login to Farmavita.Net

membership is FREE

Follow us on:

bpe_oglas.gif




Join our LinkedIn Group

BabelFish Translator




Click Flag for Translation

Who's Online

We have 23 guests online

Farmavita.Net RSS News


Products

Click to Products

JobLine

Click here ...Post a Job for Free

Reports

Click to Reports

Events

Click to Events

CRAMS

Click to CRAMS